via University of South Australia
University of South Australia researchers are a step closer to finding a new biomarker for osteoarthritis, a painful condition which affects more than two million Australians and costs the country an estimated $23 billion a year.
Using new state-of-the-art imaging techniques to identify signs of osteoarthritis (OA), UniSA scientists are learning more about changes at the molecular level which indicate the severity of cartilage damage.
A study led by PhD student Olivia Lee and her supervisor Associate Professor Paul Anderson using mass spectrometry imaging (MSI) has mapped complex sugars on OA cartilage, showing different sugars are associated with damaged tissue compared to healthy tissue.
The finding will potentially help overcome one of the main challenges of osteoarthritis research – identifying why cartilage degrades at different rates in the body.
“Despite its prevalence in the community, there is a lot about osteoarthritis that we don’t understand,” Prof Anderson says.
“It is one of the most common degenerative joint diseases, yet there are limited diagnostic tools, few treatment options and no cure.”
Existing OA biomarkers are still largely focused on bodily fluids which are neither reliable nor sensitive enough to map all the changes in cartilage damage.
By understanding the biomolecular structure at the tissue level and how the joint tissues interact in the early stages of osteoarthritis, UniSA researchers say any molecular changes could be targeted to help slow the progression of the disease with appropriate medication or treatment.
Osteoarthritis affects an estimated 2.2 million Australians and more than 300 million people worldwide, with those aged over 45 most at risk. Being female, overweight, and having existing joint injuries increases the risk of getting OA.
In Australia, $3.75 million is spent on joint replacements alone for osteoarthritis patients each year, and other indirect costs related to lost work productivity and loss of wellbeing are estimated to be more than $23 billion a year.
In a recent paper published in the International Journal of Molecular Sciences, Lee and her colleagues from UniSA’s Musculoskeletal Biology Research Laboratory and the Future Industries Institute explore how advances in mass spectrometry imaging (MSI) to detect OA are promising.
“To date, diagnosing osteoarthritis has relied heavily on x-rays or MRI, but these provide limited information and don’t detect biomolecular changes that signal cartilage and bone abnormalities,” Lee says.
“By contrast, alternative imaging methods such as MSI can identify specific molecules and organic compounds in the tissue section.”
MSI has already demonstrated its strengths in identifying biomarkers for different types of cancer, and UniSA researchers are hopeful it can achieve the same for early diagnosis of osteoarthritis.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Osteoarthritis
- PARADIGM BIOPHARMACEUTICALS SPOTLIGHTS POTENTIAL BREAKTHROUGH OSTEOARTHRITIS TREATMENT AT BIOLOGICAL ASSOCIATION 3RD ANNUAL SUMMIT
Global Clinical Head Dr. Mukesh Ahuja Presented, “Injectable Pentosan Polysulfate Sodium for Knee Osteoarthritis: A Potential Disease-Modifying Osteoarthritis Drug.” NEW YORK, May 24, 2022 /PRNewswire ...
- Global Orthopedic Braces and Supports Market Analysis Report 2022-2030 - ResearchAndMarkets.com
The “Orthopedic Braces and Supports Market Size, Share & Trends Analysis Report by Products (Braces & Supports Type, Pain Management Products), by End User (Orthopedic Clinics, OTC, Hospitals), by ...
- Arthritis: Take Steps to Reduce Pain, Increase Mobility
Arthritis is one of the most common health conditions in the United States, affecting about one in four adults, or more than 58 million men and women. May is National Arthritis Awareness Month, a ...
- Hip resurfacing is another type of hip replacement surgery
Q: My older brother worked construction his whole life, and now he has bad arthritis in his left hip. Instead of a hip replacement, his doctors want to do hip resurfacing. What is that?
- Hand osteoarthritis: Warning signs and treatment options
This content is sponsored by MedStar Washington Hospital Center. Osteoarthritis is the most common form of arthritis, and it affects millions of people around the world. While there isn’t a cure ...
Go deeper with Google Headlines on:
Osteoarthritis
Go deeper with Bing News on:
Osteoarthritis biomarker
- J&J's Janssen presents new data at Digestive Disease Week for Tremfya in Crohn's disease
Janssen unit on Tuesday said new data from a phase 2 study of its Tremfya therapy for inflammatory bowel diseases ((IBD)) showed that 47.5%-66.7% ...
- Candidate biomarkers identified for psoriasis progression
Candidate biomarkers for disease progression in psoriasis have been identified, according to a review published online April 28 in the British Journal of Dermatology.
- Northwestern University: Treating knee osteoarthritis without surgery
Dr. Prakash Jayabalan has long pondered why more non-operative treatment options aren’t available to patients with knee osteoarthritis (OA), particularly because it is the most common cause of ...
- Treating knee osteoarthritis without surgery
Dr. Prakash Jayabalan has long pondered why more non-operative treatment options aren't available to patients with knee osteoarthritis (OA), particularly because it is the most common cause of ...
- Artificial Intelligence Revolution Has Started With Arthritis
‘The changes in the structure of bones in arthritis can be very accurately detected using artificial intelligence, which makes classification more precise.’ Missing biomarkers currently often make ...